欧盟法规
ECHA物质C&L通报上下游产品
CAS号1069-31-4 DL-鸟氨酸 盐酸盐 | CAS号138377-80-7 3-氨基哌啶-2-酮盐酸盐 | CAS号3184-13-2 L-鸟氨酸盐酸盐 | CAS号81084-75-5 ornithine methy... | CAS号34294-79-6 (S)-3-氨基哌啶-2-酮盐酸盐 | CAS号34294-79-6 (S)-3-氨基哌啶-2-酮盐酸盐 | CAS号88763-76-2 (R)-3-氨基哌啶-2-酮 | CAS号885-70-1 5,11-二氢-6H-吡啶并[... | CAS号99780-98-0 3-(B°C-氨基)-2-哌啶酮 | CAS号25219-59-4 3-甲氧基-2-哌啶酮 | CAS号28797-48-0 5,11-二氢-11-氯乙酰基... | CAS号19365-08-3 3-羟基-2-哌啶酮 | CAS号28797-61-7 哌仑西平 | CAS号84772-30-5 2-amino-N-(2-ox... | CAS号91417-29-7 3-氨基-1-甲基-哌啶-2-酮📜L-鸟氨酸盐酸盐置于aluminum Oxide,Sodium Hydroxide体系中,用 水,甲苯 用作溶剂,化学反应生成3-氨基-2-哌啶酮
参考文献:双重氮化合物的多米诺反应:乙酸铑(II)催化环氧和表硫桥连的杂环基喹喔啉酮类似物的非对映选择性合成
标题:双重氮化合物的多米诺反应:乙酸铑(II)催化环氧和表硫桥连的杂环基喹喔啉酮类似物的非对映选择性合成
摘要:摘要 双重氮化合物的乙酸铑(II)催化的多米诺反应以立体选择性方式提供环氧和表硫桥连的杂环稠合喹啉嗪酮系统.受体重氮官能团的存在以化学选择性的方式导致选择性的分子间x-h插入反应,然后受体/受体重氮官能团参与异麦草酮/硫代异丁烯酮1,3-偶极的形成,随后在非对映选择性中进行分子内环加成方式.该多米诺反应能够构建具有四个立体生成中心的环氧和表硫桥连的杂环稠合喹啉嗪酮环系统.布朗斯台德酸诱导的氧杂桥连的三环化合物的反应以区域选择性方式提供开环醇产物. 双重氮化合物的乙酸铑(II)催化的多米诺反应以立体选择性方式提供环氧和表硫桥连的杂环稠合喹啉嗪酮系统.受体重氮官能团的存在以化学选择性的方式导致选择性的分子间x-h插入反应,然后受体/受体重氮官能团参与异麦草酮/硫代异丁烯酮1,3-偶极的形成,随后在非对映选择性中进行分子内环加成方式.该多米诺反应能够构建具有四个立体生成中心的环氧和表硫桥连的杂环
Doi:10.1055/s-0035-1560441
海关参考信息
- 2912110000-甲醛
2912120000-乙醛
2921211000-乙二胺
2924199090-其他无环酰胺 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:EA-002100-B1
优先权日:1996-12-23
标题:CYCLOALCYL COMPOUNDS, LACTAMS, LACTONES AND RELATED COMPOUNDS CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS AND METHODS OF INHIBITING THE SURVIVAL AND / OR SYNTHESIS OF β-AMYLOUS PEPTIDE SOFTWARE AGREED SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE, SOFTWARE AND SOFTWORK
专利号:US-9487523-B2
优先权日:2012-03-14
标题 :Process for making CGRP receptor antagonists
发明人:BELYK KEVIN M; CLEATOR EDWARD; KUO SHEN-CHUN; MALIGRES PETER EMMANUEL; XIANG BANGPING; YASUDA NOBUYOSHI; YIN JIANGUO
权利人:MERCK SHARP & DOHME
摘要:The invention encompasses a novel process for making piperidinone carboxamide indane and azainane derivatives, which are CGRP receptor antagonists useful for the treatment of migraine, utilizing a highly effective spiroacid synthesis.
专利号:JP-3812952-B2
优先权日:1996-12-23
标 题:Cycloalkyl, lactam, lactone and related compounds and pharmaceutical compositions thereof, and methods of inhibiting the release of β-amyloid peptide and / or synthesis thereof using the compounds
专利号:TW-568914-B
优先权日:1996-12-23
标题 :Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
专利号:HR-P970705-A2
优先权日:1996-12-23
标 题:CYCLOALKYL, LACTAM, LACTONE AND RELATED COMPOUNDS, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING 'beta' -AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS
专利号:KR-20000069654-A
优先权日:1996-12-23
标题:Cycloalkyl, Lactam, Lactone and Related Compounds, Pharmaceutical Compositions Comprising Same and Methods for Inhibiting β-Amyloid Peptide Release and/or Its Synthesis by Use of Such Compounds